Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma

Zinzani, Pier Luigi; Salles, Gilles; Moskowitz, Alison J.; Santoro, Armando; Mehta, Amitkumar; Barr, Paul M.; Mehta-Shah, Neha; Collins, Graham P.; Ansell, Stephen M.; Brody, Joshua D.; Domingo-Domenech, Eva; Johnson, Nathalie A.; Cunningham, David; Ferrari, Silvia; Lisano, Julie; Krajewski, Jennifer; Wen, Rachael; Akyol, Alev; Crowe, Russell; Savage, Kerry J.